Effectiveness and safety of oral vancomycin in non‐primary sclerosing cholangitis paediatric inflammatory bowel disease

Documenti analoghi

• Prognosis of pediatric‐onset inflammatory bowel disease associated with primary sclerosing cholangitis: A population‐based study
  di: Marie‐Laura Godet, et al.
  Pubblicazione: (2025)
• Caregiver‐reported symptom burden and preferences for therapeutic goals in pediatric primary sclerosing cholangitis
  di: Holly Payton Shifman, et al.
  Pubblicazione: (2024)
• Hyperamylasaemia in paediatric inflammatory bowel disease: Aetiology, outcomes and genetic determinants
  di: Fernando Vázquez López, et al.
  Pubblicazione: (2026)
• Noninvasive monitoring with bowel ultrasound (NIMBUS) in paediatric inflammatory bowel disease: Feasibility in a single centre
  di: Zachary Green, et al.
  Pubblicazione: (2025)
• Portal hypertension in doublecortin domain‐containing protein 2 (DCDC2)‐related neonatal sclerosing cholangitis
  di: Prabhsaran Kaur, et al.
  Pubblicazione: (2024)